Showing 4,341 - 4,360 results of 4,407 for search '"pharmaceutical"', query time: 0.07s Refine Results
  1. 4341
  2. 4342
  3. 4343
  4. 4344
  5. 4345
  6. 4346
  7. 4347
  8. 4348
  9. 4349

    ASSESSMENT OF THE REGION'S INVESTMENT ENVIRONMENT AND POLICY INSTRUMENTS FOR THE IMPLEMENTATION OF ITS INVESTMENT POTENTIAL IN WARTIME by Ruslan Boiko, Roman Martsenyuk, Arsen Protsykevych

    Published 2024-12-01
    “…It is substantiated that effective instruments of regional investment policy in the context of critical instability are: military risk insurance and diversification; use of concession agreements; private and public investments in the defence industry and critical infrastructure industries/sectors (energy, transport and logistics, medicine and pharmaceuticals, natural resources); support for innovative and technological startups in the areas of security, the real economy and infrastructure; stimulation of investments in human resources; support for investments in business projects of demobilised persons, war veterans and other combatants; encouragement of investments in the development of export potential to maintain the country's financial security.…”
    Get full text
    Article
  10. 4350

    Seroprevalence of Foot and Mouth Disease Virus Infection in Some Wildlife and Cattle in Bauchi State, Nigeria by Y. J. Atuman, C. A. Kudi, P. A. Abdu, O. O. Okubanjo, A. Abubakar, Y. Wungak, H. G. Ularamu

    Published 2020-01-01
    “…Wild animals were immobilized using a combination of etorphine hydrochloride (M99® Krüger-Med South Africa) at 0.5–2 mg/kg and azaperone (Stresnil®, Janssen Pharmaceuticals (Pty.) Ltd., South Africa) at 0.1 mg/kg using a Dan-Inject® rifle (Dan-Inject APS, Sellerup Skovvej, Denmark) fitted with a 3 ml dart syringe and for reversal, naltrexone (Trexonil® Kruger-Med South Africa) at 1.5 mg IM was used, and cattle were restrained by the owners for blood collection. …”
    Get full text
    Article
  11. 4351

    Review of Challenges in Performing Real-World Evidence Studies for Nonprescription Products by Maihöfner C, Mallick-Searle T, Vollert J, Kalita P, Sood Sethi V

    Published 2025-01-01
    “…Ltd, SingaporeCorrespondence: Vidhu Sood Sethi, GSK Consumer Healthcare Singapore Pte Ltd (Co Regn No. 201309040M), 23 Rochester Park #03-02, 139234, Singapore, Tel +6596447203, Email vidhu.x.sethi@haleon.comAbstract: In recent years, regulatory authorities have signaled a willingness to consider real-world evidence (RWE) data to support applications for new claims and indications for pharmaceuticals. Historically, RWE studies have been the domain of prescription drugs, driven by the fact that clinical data on patients are routinely captured in medical records, claims databases, registries, etc. …”
    Get full text
    Article
  12. 4352

    Optimizing Risk-based Stock Return Prediction in Tehran Stock Exchange industries: A Data Envelopment Analysis by Hamidreza Akhbari, Heydar Mohammadzadeh Salteh, Rasoul Baradaran Hassanzadeh, Mehdi Zeynali

    Published 2024-06-01
    “…Future research should explore and assess the optimization of stock return forecasting in other significant industries like pharmaceuticals, electricity, steam, hot water supply, etc. to compare and evaluate their outcomes alongside the findings of this study.…”
    Get full text
    Article
  13. 4353
  14. 4354
  15. 4355
  16. 4356
  17. 4357
  18. 4358
  19. 4359
  20. 4360